XML 35 R23.htm IDEA: XBRL DOCUMENT v3.26.1
Stockholders’ Equity (Tables)
3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of Warrants Outstanding

A summary of common stock warrant activity, including warrants to purchase common stock that were issued in conjunction with the Company’s public offerings, but excluding pre-funded warrants, is presented below.

 

   Number of Shares   Weighted Average Exercise Price   Weighted Average Remaining Contractual Life (in Years) 
Warrants outstanding at December 31, 2025   8,512,614    1.914      
Issued   -           
Exercised   -           
Expired   (11,331)          
Warrants outstanding at March 31, 2026   8,501,283    1.8677    3.56 

Schedule of Warrants Outstanding and Exercisable

At March 31, 2026, the outstanding warrants are exercisable at the following prices per common share:

 

Exercise Price   Warrants Outstanding (Shares) 
$1.00    6,355,214 
 2.29    414,784 
 3.0188    32,609 
      6,802,607 

Summary of Activities Related to Common Stock Warrants

The following table presents a summary of activities related to pre-funded warrants.

 

   Number of Shares 
Pre-funded warrants outstanding at December 31, 2025   545,521 
Issued   - 
Exercised   (283,021)
Expired   - 
Pre-funded warrants outstanding at March 31, 2026   262,500 

Schedule of Common Stock Warrants and Pre-Funded Warrant

The following table presents a summary of total number of common stock warrants and pre-funded warrants.

 

Warrant Type  3/31/2026 
Common stock warrants   8,501,283 
Pre-funded warrants   262,500 
Total warrants outstanding   8,763,783